Indegene, a global healthcare-IT leader in the life sciences industry, has acquired a majority stake in London-based DT Associates, a consulting company exclusively focused on helping pharmaceutical companies in customer experience (CX) and digital operations (DX) in a deal worth $10 million.
DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting, according to company executives. Indgene is backed by Infosys co-founder NS Raghavan’s Nadathur Holdings.
Founded in 2014, London based DT Associates helped pharmaceuticals identify, plan for and capture the commercial opportunity behind transformation, and developed proprietary solutions for the objective measurement of Customer Experience (CX) and Digital Maturity (DX). Its clients include companies such as PfizerNSE 1.35 %, Sanofi, AstraZeneca, Takeda and Novo Nordisk.
It is Indgene’s latest acquisition following its buyout of US-based Enicma Group for $16 million in 2016 to ramp up its analytics and omni-channel digital solutions capability. It had also bought Canada’s Skura Technologies for $9 million in the same year. In December 2015, the company had acquired SmartCare, a health analytics platform, from Connecticut-based Vantage Point.
“While we offer extensive capabilities already in customer experience and hybrid selling enablement, marketing technology, data & analytics, and medical expertise, with the addition of DT we can truly help our clients end-to-end—from objectively measuring the current maturity of digital and customer excellence, to designing commercial models,”said Manish Gupta, Co-Founder & CEO, Indegene.
Founded in 1998, Bengaluru based Indegene helps US-based life sciences companies through its analytics, technology, operations and medical expertise (ATOM). Its CEO Manish Gupta, an IIT-BHU and IIM Ahmedabad alumnus who worked in Infosys up to 1998, is one of the co-founders.
Indegene which was catering to the domestic market till 2004, expanded its business globally and focussed more into the overseas market. In 2015, Infosys co-founder NS Raghavan’s Nadathur Holdings acquired stake in Indgene from existing investor KITVEN Fund, which had invested in Indegene in 2002.
”The prospect of helping our clients beyond DX/CX measurement, benchmarking, and transformation management consulting, with deep expertise and capabilities in establishing consolidated centers of excellence for digital content, channel operations, performance measurement, and customer innovation is very exciting,” said Dennis van Rooij, Managing Partner and co-founder of DT.
Indegene’s major competitors include US based Veeva Systems Inc, ZS Associates, Accenture, Welltok, Oracle and cloud based platform Inovalon.
